Jornal Internacional de Desenvolvimento e Pesquisa de Drogas

  • ISSN: 0975-9344
  • Índice h do diário: 44
  • Pontuação de citação de diário: 59.93
  • Fator de impacto do periódico: 48.80
Indexado em
  • Genamics JournalSeek
  • Infraestrutura Nacional de Conhecimento da China (CNKI)
  • CiteFactor
  • Scimago
  • Diretório de Indexação de Periódicos de Pesquisa (DRJI)
  • OCLC- WorldCat
  • publons
  • MIAR
  • Comissão de Bolsas Universitárias
  • Euro Pub
  • Google Scholar
  • SHERPA ROMEU
  • Laboratórios secretos do mecanismo de pesquisa
  • ResearchGate
Compartilhe esta página

Abstrato

Therapy Compliance in Hypertension: Indian Clinicians’ Viewpoint

Dave Nilanj S, Sharma Ramandeep T, Kulkarni Girish R and Sen Sankar

Context: Poor compliance to antihypertensive therapies has been linked to a variety of problems, including poor blood pressure control, rehospitalisation, and increased healthcare resource utilization.

Setting and Design: Considering this, a cross-sectional survey of health care physicians (HCPs) treating hypertension from government or private practice across the India was conducted.

Aims: The purpose of the survey was to capture clinician viewpoint on the therapy compliance in the management of hypertension.

Methods and Materials: This was a paper-based survey where all HCPs were asked to respond to survey questionnaire during a personal meeting with the study interviewer.

Results: Total 2746 clinicians from more than 150 cities across the India were involved in this survey. Approximately 69% of clinicians believed that more than 1/4th of patients are not controlled for their hypertension. Out of all responders, 93.5% expressed that non-compliance to the medicine is one of the major reasons for the uncontrolled hypertension. Around 94% of responders expressed that patient compliance program can improve the compliance to the medicine in hypertension management.

Conclusions: Indian clinicians feel that uncontrolled hypertension is still be a widely prevalent problem in spite of availability of effective antihypertensive drugs and non-compliance to the medication is one of the major modifiable risk factor for this.